Sartorius | SRT3 - PE Price to Earnings


Sartorius reported 47.29 in PE Price to Earnings for its fiscal quarter ending in September of 2026.





Pe Change Date
Akebia Therapeutics 1.63K 1.6K Dec/2025
Dianthus Therapeutics 3.8 1.53 Sep/2024
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
IQVIA Holdings 29.03 7.58 Sep/2026
Moderna 27.22 14.51 Jun/2023
Organon & Co 17.56 3 Sep/2026
Revvity 56.86 20.39 Sep/2026
Sartorius 47.29 5.7 Sep/2026
Tectonic Therapeutic 4.01 0.63 Mar/2024
Viatris 468.91 434.44 Sep/2026
Xeris Pharmaceuticals 92.28 16.23 Jun/2026